FDA asks 23andme to stop marketing of unapproved test and device
After months of negotiations, FDA finally lost patience and sends a warning letter to Google-backed 23andme, a genome testing company. 23andme was marketing its saliva based genetic test device and the test (Personal Genome Service) itself without an obligatory marketing clearance. What FDA’s letter means The letter is very direct and harsh and its…